Acumen Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.08-$5.09 |
Market Cap | $142.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $329,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$32.3M |
Diluted EPS | -$1.38 |
News
See moreYahoo Finance • last year
Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures
Yahoo Finance • last year
Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights
Yahoo Finance • last year
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
Yahoo Finance • last year
Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023
About
CEO | Mr. Daniel J. O'Connell M.B.A. |
CFO | Mr. Matt Zuga |
Address | 427 Park Street, Charlottesville, VA, United States, 22902 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 51 |
